Improved survival after single-unit cord blood transplantation using fludarabine and melphalan-based reduced-intensity conditioning for malignant lymphoma: impact of melphalan dose and graft-versus-host disease prophylaxis with mycophenolate mofetil

Kazuki Sakatoku, Sung Won Kim, Hiroshi Okamura, Minoru Kanaya, Koji Kato, Satoshi Yamasaki, Naoyuki Uchida, Hikaru Kobayashi, Takahiro Fukuda, Nobuyuki Takayama, Jun Ishikawa, Hideyuki Nakazawa, Masatoshi Sakurai, Takashi Ikeda, Tadakazu Kondo, Satoshi Yoshioka, Toshihiro Miyamoto, Takafumi Kimura, Tatsuo Ichinohe, Yoshiko AtsutaEisei Kondo

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Improved survival after single-unit cord blood transplantation using fludarabine and melphalan-based reduced-intensity conditioning for malignant lymphoma: impact of melphalan dose and graft-versus-host disease prophylaxis with mycophenolate mofetil'. Together they form a unique fingerprint.

Medicine & Life Sciences